LeafNLP Demos
Back to explore

Report #2865536

Received Oct 13, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
71 yrs
State
NC
Recovered
Unknown
Vaccinated
Oct 2, 2025
Onset
Oct 2, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALS2B5NJ9—

Symptoms (1)

Extra dose administered

Symptom narrative

Extra dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a elderly male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number B5NJ9, expiry date 05-DEC-2026) for prophylaxis. Previously administered products included Arexvy (Received 1st dose of Arexvy vaccine on 25-OCT-2023). On 02-OCT-2025, the patient received the 2nd dose of Arexvy. On 02-OCT-2025, an unknown time after receiving Arexvy, the patient experienced extra dose administered (Verbatim: Extra dose). The outcome of the extra dose administered was not applicable.